E2F-1 inhibits ferroptosis in osteosarcoma cells by activating the PSAT1/Xct/GPX4 signaling axis DOI Creative Commons
Po Wang, Jun Xiao, Jin Zeng

и другие.

Research Square (Research Square), Год журнала: 2024, Номер unknown

Опубликована: Фев. 7, 2024

Abstract Osteosarcoma is a common primary malignant bone tumour that occurs mainly in children and adolescents has poor survival prognosis. Currently, ferroptosis newly defined form of cell death, but the mechanism between it osteosarcoma unclear. To further investigate relationship ferroptosis, important to search for new biomolecular factors. We used bioinformatics dig deeper into gene PSAT1, which closely associated with osteosarcoma. Although PSAT1 been reported other types tumours plays an role development many tumours, such as melanoma breast cancer, little research done field explore its association we designed relevant experiments. Subsequently, predicted transcription factor E2F-1 from frediction database experimentally verified could inhibit OS cells by activating PSAT1. The results indicated promote process cells. This finding implies may become target diagnosis treatment future, bringing breakthroughs clinical practice.

Язык: Английский

Targeting Ferroptosis in Bone-Related Diseases: Facts and Perspectives DOI Creative Commons
Hao Chen, Zhongyu Han, Yi Wang

и другие.

Journal of Inflammation Research, Год журнала: 2023, Номер Volume 16, С. 4661 - 4677

Опубликована: Окт. 1, 2023

Abstract: Ferroptosis is a new cell fate decision discovered in recent years. Unlike apoptosis, autophagy or pyroptosis, ferroptosis characterized by iron-dependent lipid peroxidation and mitochondrial morphological changes. involved variety of physiological pathological processes. Since its discovery, has been increasingly studied concerning bone-related diseases. In this review, we focus on the latest research progress prospects, summarize regulatory mechanisms ferroptosis, discuss role pathogenesis diseases, such as osteoporosis (OP), osteoarthritis (OA), rheumatoid arthritis (RA), osteosarcoma (OS), well therapeutic potential. Keywords: death, iron accumulation, peroxidation, diseases

Язык: Английский

Процитировано

20

Baicalin protects against hepatocyte injury caused by aflatoxin B1 via the TP53-related ferroptosis Pathway DOI Creative Commons

H. Zhang,

Jian-Zhu Luo,

Chenlu Lan

и другие.

Ecotoxicology and Environmental Safety, Год журнала: 2024, Номер 281, С. 116661 - 116661

Опубликована: Июль 1, 2024

Baicalin has antioxidative, antiviral, and anti-inflammatory properties. However, its ability to alleviate oxidative stress (OS) DNA damage in liver cells exposed aflatoxin B1 (AFB1), a highly hepatotoxic compound, remains uncertain. In this study, the protective effects of baicalin on AFB1-induced hepatocyte injury mechanisms underlying those were investigated. Stable cell lines expressing CYP3A4 established using lentiviral vectors assess levels by conducting assays determine content reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD). Additionally, was evaluated 8-hydroxy-2-deoxyguanosine (8-OHdG) comet assays. Transcriptome sequencing, molecular docking, vitro experiments conducted injury. vivo, rat model induced AFB1 used evaluate baicalin. vitro, significantly attenuated caused due OS, as determined decrease ROS, MDA, SOD levels. also considerably decreased hepatocytes. This effect found be closely associated with TP53-mediated ferroptosis pathway. To elaborate, physically interacts P53, leading suppression expression GPX4 SLC7A11, which turn inhibits ferroptosis. vivo findings showed that AFB1-treated tissues, γ-H2AX an increase SLC7A11 Overexpression TP53 weakened can OS via theoretical foundation for use protecting from toxic AFB1.

Язык: Английский

Процитировано

4

Translational Potential of Baicalein in Mitigating RSL3-Induced Ferroptosis in Fibroblasts: Implications for Therapeutic Interventions DOI Creative Commons

Pao‐Jen Kuo,

Cheng‐Shyuan Rau,

Yi-Chan Wu

и другие.

International Journal of Medical Sciences, Год журнала: 2024, Номер 21(7), С. 1257 - 1264

Опубликована: Янв. 1, 2024

Ferroptosis is an iron-driven cell-death mechanism that plays a central role in various diseases. Recent studies have suggested baicalein inhibits ferroptosis, making it promising therapeutic candidate.

Язык: Английский

Процитировано

1

Decoding ferroptosis: transforming orthopedic disease management DOI Creative Commons

Guochen Huo,

Yumeng Lin,

Lusheng Liu

и другие.

Frontiers in Pharmacology, Год журнала: 2024, Номер 15

Опубликована: Дек. 6, 2024

As a mechanism of cell death, ferroptosis has gained popularity since 2012. The process is distinguished by iron toxicity and phospholipid accumulation, in contrast to autophagy, apoptosis, other death mechanisms. It implicated the advancement multiple diseases across body. Researchers currently know that osteosarcoma, osteoporosis, orthopedic disorders are caused NRF2, GPX4, star proteins. effective relief osteoarthritis symptoms from deterioration been confirmed clinical treatment with inhibitors. At same time, it should be reminded mechanisms involved regulate not understood. In this manuscript, we present discovery ferroptosis, role variety diseases. We expect manuscript can provide new perspective on diagnosis related

Язык: Английский

Процитировано

1

E2F-1 inhibits ferroptosis in osteosarcoma cells by activating the PSAT1/Xct/GPX4 signaling axis DOI Creative Commons
Po Wang, Jun Xiao, Jin Zeng

и другие.

Research Square (Research Square), Год журнала: 2024, Номер unknown

Опубликована: Фев. 7, 2024

Abstract Osteosarcoma is a common primary malignant bone tumour that occurs mainly in children and adolescents has poor survival prognosis. Currently, ferroptosis newly defined form of cell death, but the mechanism between it osteosarcoma unclear. To further investigate relationship ferroptosis, important to search for new biomolecular factors. We used bioinformatics dig deeper into gene PSAT1, which closely associated with osteosarcoma. Although PSAT1 been reported other types tumours plays an role development many tumours, such as melanoma breast cancer, little research done field explore its association we designed relevant experiments. Subsequently, predicted transcription factor E2F-1 from frediction database experimentally verified could inhibit OS cells by activating PSAT1. The results indicated promote process cells. This finding implies may become target diagnosis treatment future, bringing breakthroughs clinical practice.

Язык: Английский

Процитировано

0